Physician profile
Mark Philip Mantell
NPI 1104984046
$4,256.76
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2021: $105 · 2022: $1,923 · 2023: $2,000 · 2024: $40.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $40.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $40.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $2,000.00 | 2023 | Mirragen Advanced Wound Matrix |
| Medtronic, INC. | $1,304.80 | 2022 | |
| Becton, Dickinson and Company | $450.00 | 2022 | |
| Getinge USA Sales, LLC | $259.80 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $100.62 | 2022 | |
| Baxter Healthcare | $40.03 | 2024 | Preveleak |
| Acera Surgical, INC. | $27.28 | 2022 | |
| Lemaitre Vascular, INC. | $22.80 | 2022 | |
| Biom'Up Sa | $19.00 | 2019 | |
| Boston Scientific Corporation | $17.75 | 2022 | |
| Smith+Nephew, INC. | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mantell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.